Equipalazone inj. 50 ml
Phenylbutazone injectable, for relief against inflammation, pain and lameness.
- Solution for injection, 50ml
- Phenylbutazone 200mg/ml
Composition
Equipalazone is a sterile, aqueous solution for injection, containing Phenylbutazone 200mg/ml
Indications
Equipalazone solution for injection is indicated in the treatment of musculoskeletal disorders in horses and ponies where the anti-inflammatory analgesic properties of phenylbutazone can offer relief against inflammation, pain and lameness (for example, osteoarthritis, acute and chronic laminitis, bursitis and carpitis).
Contra-indications
The safety of phenylbutazone in pregnancy has not been established.
Not be used in horses intended for human consumption.
Precautions of storage
Store in refrigerator, 2°C - 8°C
| Nr. | 26024 |
|---|---|
| EAN | 5055031400171 |
| Registration number | Cascade |
| Brands | Dechra |
| Cooled | Yes |
| Active Ingredient | Phenylbutazone |
| Withdrawal period | 0 days |
| Ingredients | Contains: |
| Batch number | 112837 |
| Batch expiry date | Oct 31, 2021 |
| Units per outer box | 0 |
Instructions for use
Horse: 450 kg, max. 10 ml (4,4 mg phenylbutazone/kg)
Pony: 225 kg, max. 5 ml (4,4 mg phenylbutazone/kg)
To be administered by very slowly intravenous injection in a single dose, which may be followed if necessary by oral phenylbutazone therapy commencing 24 hours after the injection. In acute cases and in hospitalized animals the injection may be administered once daily for not more than five consecutive days.